Dubai: During the peak of the pandemic, G42 Healthcare, a home-grown, Abu Dhabi-based company, facilitated the 4Humanity project that involved the world’s first ever Phase III clinical trials of a deactivated vaccine against COVID-19 - Sinopharm. Over 43,000 volunteers participated in the pan-Arab Phase III trial from over 125 nationalities. This actually set the stage for the rollout of the vaccine in the community. The World Health Organisation (WHO) granted it approval for emergency use last month. As the Arab Health Congress 2021 begins, Gulf News spoke to Dr Walid Zaher, Chief Research Officer and Vaccine Project Leader at G42, to gain an insight into his experience of managing the his
Hence then, the article about covid 19 vaccine expert in uae explains efficacy of sinopharm jab booster dose was published today ( ) and is available onKhaleej Times ( United Arab Emirates ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( COVID-19 vaccine expert in UAE explains efficacy of Sinopharm jab, booster dose )